Avance Clinical Email Format
Biotechnology ResearchSouth Australia, Australia201-500 Employees
Avance Clinical is a full-service Contract Research Organization focused on early-phase clinical trials for biotech sponsors, headquartered in Firle, South Australia, with operations spanning New Zealand, Asia, North America, and Europe. It highlights Australia’s regulatory environment—fast ethics approvals, no IND requirement, and a 43.5% R&D tax rebate—as factors that can shorten development timelines and reduce costs. Across more than 250 indications and all therapeutic areas, the company aims to deliver rapid, robust data that meet global regulator expectations, supported by an agile, innovation-driven service model and customized client support. Its client base consists of biotech sponsors seeking to advance from preclinical work to late-phase studies, with engagements designed to be customized and flexible rather than one-size-fits-all. In January 2026, Avance Clinical expanded its oncology capabilities through the acquisition of LumaBridge, establishing an Oncology Center of Excellence to strengthen its global offering.